Dearborn Partners’s Merck MRK Stock Holding History

Dearborn Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.22M	Sell	35,043 -185,057	-84%	-$21.4M	0.23%	73
2025 Q4	$23.2M	Sell	220,100 -8,799	-4%	-$826K	1.16%	41
2025 Q3	$19.2M	Buy	228,899 +2,935	+1%	+$242K	0.9%	43
2025 Q2	$17.9M	Buy	225,964 +2,694	+1%	+$214K	0.85%	49
2025 Q1	$20M	Sell	223,270 -57,396	-20%	-$5.36M	0.96%	44
2024 Q4	$27.9M	Sell	280,666 -3,753	-1%	-$387K	1.17%	41
2024 Q3	$32.3M	Sell	284,419 -6,570	-2%	-$781K	1.31%	37
2024 Q2	$36M	Sell	290,989 -2,611	-0.9%	-$336K	1.56%	23
2024 Q1	$38.7M	Sell	293,600 -108,768	-27%	-$13.4M	1.66%	19
2023 Q4	$43.9M	Sell	402,368 -8,546	-2%	-$887K	1.6%	24
2023 Q3	$42.3M	Buy	410,914 +992	+0.2%	+$107K	1.66%	19
2023 Q2	$47.3M	Sell	409,922 -98,752	-19%	-$11.2M	1.81%	15
2023 Q1	$54.1M	Buy	508,674 +856	+0.2%	+$92.4K	2.13%	9
2022 Q4	$56.3M	Sell	507,818 -4,637	-0.9%	-$474K	2.27%	8
2022 Q3	$44.1M	Buy	512,455 +2,130	+0.4%	+$190K	1.95%	13
2022 Q2	$46.5M	Sell	510,325 -1,663	-0.3%	-$147K	1.97%	12
2022 Q1	$42M	Buy	511,988 +14,283	+3%	+$1.13M	1.59%	25
2021 Q4	$38.1M	Buy	497,705 +3,076	+0.6%	+$245K	1.38%	33
2021 Q3	$37.2M	Buy	494,629 +187,443	+61%	+$14.3M	1.51%	32
2021 Q2	$23.9M	Sell	307,186 -13,562	-4%	-$1.01M	0.96%	49
2021 Q1	$23.6M	Buy	320,748 +6,210	+2%	+$458K	1.01%	49
2020 Q4	$24.6M	Buy	314,538 +3,906	+1%	+$299K	1.12%	45
2020 Q3	$24.6M	Buy	310,632 +1,100	+0.4%	+$86.2K	1.22%	39
2020 Q2	$22.8M	Sell	309,532 -7,845	-2%	-$591K	1.23%	39
2020 Q1	$23.3M	Buy	317,377 +9,125	+3%	+$717K	1.45%	35
2019 Q4	$26.8M	Buy	308,252 +17,555	+6%	+$1.44M	1.36%	41
2019 Q3	$23.4M	Buy	290,697 +4,376	+2%	+$351K	1.35%	38
2019 Q2	$22.9M	Buy	286,321 +10,377	+4%	+$795K	1.4%	36
2019 Q1	$21.9M	Buy	275,944 +6,339	+2%	+$474K	1.46%	31
2018 Q4	$19.7M	Buy	269,605 +3,294	+1%	+$233K	1.52%	25
2018 Q3	$18M	Buy	266,311 +2,935	+1%	+$187K	1.26%	40
2018 Q2	$15.3M	Sell	263,376 -13,609	-5%	-$768K	1.19%	42
2018 Q1	$14.4M	Sell	276,985 -9,216	-3%	-$498K	1.11%	45
2017 Q4	$15.4M	Sell	286,201 -8,988	-3%	-$498K	1.11%	43
2017 Q3	$18M	Sell	295,189 -621	-0.2%	-$37.6K	1.33%	37
2017 Q2	$18.1M	Buy	295,810 +6,425	+2%	+$391K	1.34%	37
2017 Q1	$17.5M	Buy	289,385 +11,557	+4%	+$701K	1.36%	36
2016 Q4	$15.6M	Buy	277,828 +6,637	+2%	+$388K	1.3%	35
2016 Q3	$16.1M	Buy	271,191 +4,170	+2%	+$244K	1.36%	32
2016 Q2	$14.7M	Buy	267,021 +8,611	+3%	+$458K	1.27%	35
2016 Q1	$13M	Buy	258,410 +13,897	+6%	+$681K	1.21%	37
2015 Q4	$12.3M	Buy	244,513 +24,043	+11%	+$1.21M	1.15%	38
2015 Q3	$10.4M	Buy	220,470 +5,354	+2%	+$284K	1.04%	40
2015 Q2	$11.7M	Buy	215,116 +11,342	+6%	+$636K	1.13%	33
2015 Q1	$11.2M	Buy	203,774 +23,552	+13%	+$1.33M	0.98%	36
2014 Q4	$9.77M	Buy	180,222 +7,031	+4%	+$392K	0.9%	38
2014 Q3	$9.8M	Buy	173,191 +7,238	+4%	+$406K	0.95%	34
2014 Q2	$9.16M	Buy	165,953 +19,487	+13%	+$1.06M	0.9%	38
2014 Q1	$7.93M	Buy	146,466 +21,774	+17%	+$1.13M	0.87%	38
2013 Q4	$5.96M	Buy	124,692 +16,145	+15%	+$738K	0.69%	47
2013 Q3	$4.93M	Buy	108,547 +13,826	+15%	+$631K	0.65%	51
2013 Q2	$4.2M	Buy	+94,721	New	+$4.23M	0.6%	52

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dearborn Partners's MRK Position: Q1 2026 in Review

Dearborn Partners reduced its Merck (MRK) stake by 84% in Q1 2026, selling an estimated $21.4M and leaving 35,043 shares worth $4.22M. The position accounts for 0.23% of the portfolio, ranked #73.

Dearborn Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $56.3M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Dearborn Partners held 35,043 shares of Merck worth $4.22M as of Q1 2026.
Dearborn Partners sold 185,057 Merck shares in Q1 2026, an estimated $21.4M.
Merck made up 0.23% of Dearborn Partners's portfolio in Q1 2026, its #73 holding.
Dearborn Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Dearborn Partners's Merck position peaked at $56.3M in Q4 2022.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Dearborn Partners's 13F filing for Q1 2026, filed 12 May 2026.